SCT Annual Meeting Presentations & Videos
* Note that only Keynote Lectures and Trial of the Year are available to non-members for 2022 and 2023.
Members can login to view all presentations.

Discover SCT's Scientific Knowledge-Bank

  175 Learning Opportunities Found

swap_vert Primary Presenter

swap_vert Presentation Information

swap_vert Media Type(s)

Michael S. Lauer
2015 (Arlington) Annual Meeting
Founders Lecture
A Future for Clinical Trials? An NIH Perspective
 Watch Video
Study Team
2015 (Arlington) Annual Meeting
Trial of the Year Award
Mechanical versus Manual Chest Compression for Out-of-Hospital Cardiac Arrest (PARAMEDIC)
 Watch Video
James D. Neaton
2015 (Arlington) Annual Meeting
Curtis Meinert Lecture
International Trials and Tribulations
 Watch Video
Steve Goodman
2015 (Arlington) Annual Meeting
Special Presentation
Remembering David Sackett
 Watch Video
Cook et al
2015 (Arlington) Annual Meeting
Special Presentation
Workshop - Conducting Valid Trials: the Critical (and Misunderstood) Roles of Randomization and Complete Follow-Up
 Watch Video
Jennifer Gassman
2015 (Arlington) Annual Meeting
Fellows Presentation
Presentation of the Class of 2015 Fellows
 Watch Video
KyungMann Kim
2015 (Arlington) Annual Meeting
Presidential Welcome
 Watch Video
Shona Silvester
2015 (Arlington) Annual Meeting
Contributed Session
‘MINIMUM TIME/MAXIMUM QUALITY’: AUTOMATED TRACKING SYSTEMS TO IMPROVE EFFICIENCY, REDUCE THE RISK OF HUMAN ERROR AND ENSURE TIMELY DATA COLLECTION
Session Details
Edward Gaunt
2015 (Arlington) Annual Meeting
Contributed Session
A Centralized Approach to Mailing and Materials Distribution in the Gulf Long-Term Follow-up Study (GuLF STUDY)
Session Details
Raymond Carragher
2015 (Arlington) Annual Meeting
Contributed Session
A COMPARISON OF SOME METHODS FOR DETECTION OF SAFETY SIGNALS IN RANDOMISED CONTROLLED TRIALS
Session Details
Danila Azzolina
2015 (Arlington) Annual Meeting
Contributed Session
A decision making tool for non-pharmacological treatment in knee osteoarthritis
Session Details
Dong-Yun Kim
2015 (Arlington) Annual Meeting
Contributed Session
A fully sequential test for treatment effects using censored data in multi-center clinical trials
Session Details
Giulia Lorenzoni
2015 (Arlington) Annual Meeting
Contributed Session
A latent Gamma model for modelling the simultaneous effect of treatment on WOMAC subscales in osteoarthritis RCTs
Session Details
Qian Wu
2015 (Arlington) Annual Meeting
Contributed Session
A New Approach of Incorporating Biomarker Information to Identify Patient Subgroups with Enhanced Treatment Effect for Personalized Medicine
Session Details
Doussau Adelaide
2015 (Arlington) Annual Meeting
Contributed Session
A new approach to integrate toxicity grade and repeated treatment cycles in the analysis and reporting of phase I dose-finding trials
Session Details
Matthew Liang
2015 (Arlington) Annual Meeting
Contributed Session
A NOVEL USER SURVEY TO DETERMINE A CLINICALLY MEANINGFUL EFFECT SIZE IN THE PLANNING OF CSP#590 (Li+)
Session Details
Jieling Miao
2015 (Arlington) Annual Meeting
Contributed Session
A SIMPLE APPROACH FOR INCORPORATING MULTIPLE TOXICITY THRESHOLDS IN PHASE I TRIALS
Session Details
Jonathan Cook
2015 (Arlington) Annual Meeting
Contributed Session
A systematic review of the use of an expertise-based randomised trial design
Session Details
Melanie Prague
2015 (Arlington) Annual Meeting
Contributed Session
Accounting for informative missingness, interaction and interference in cluster randomized trials.
Session Details
Nolan Wages
2015 (Arlington) Annual Meeting
Contributed Session
Adaptive designs for early-phase oncology trials of combined immunotherapy regimens
Session Details
Yuko Palesch
2015 (Arlington) Annual Meeting
Contributed Session
Adaptive first interim analysis design
Session Details
David Gillespie
2015 (Arlington) Annual Meeting
Contributed Session
ADHERENCE-ADJUSRED ESTIMATES OF BENEFITS AND HARMS FROM TREATMENT WITH AMOXICILLIN FOR LOWER-RESPIRATORY-TRACT-INFECTION: SECONDARY ANALYSIS OF A 12-COUNTRY RANDOMISED PLACEBO-CONTROLLED TRIAL USING RANDOMISATION-BASED EFFICACY ESTIMATORS
Session Details
Nariman Sepehrvand
2015 (Arlington) Annual Meeting
Contributed Session
Alignment of Site versus Adjudication Committee-based diagnoses with the patients’ outcome: Lessons learned from PROACT-3 trial
Session Details
Gillian Gresham
2015 (Arlington) Annual Meeting
Contributed Session
Alternative Approaches to the Analysis of Toxicities in Randomized Clinical Trials
Session Details
Marisa De Rosa
2015 (Arlington) Annual Meeting
Contributed Session
AN ONLINE DRUG REGISTRY EXPERIENCE IN ITALY TO SUPPORT MONITORING AND REIMBURSEMENT OF INNOVATIVE DRUGS
Session Details
Jason Stock
2015 (Arlington) Annual Meeting
Contributed Session
Applying DM Processes to Research Networks and How it Differs from “Traditional” Clinical Trials
Session Details
Dario Gregori
2015 (Arlington) Annual Meeting
Contributed Session
Assessing heterogeneity of treatment effect in case of unobserved covariates via conditional frailty models
Session Details
Heather Murray
2015 (Arlington) Annual Meeting
Contributed Session
Assessing impact on post-trial cardiovascular admissions, operations and procedures using routinely collected health records: Illustrated by the 20 year follow-up of the West of Scotland Coronary Prevention Study
Session Details
Sarah Leatherman
2015 (Arlington) Annual Meeting
Contributed Session
Assessing the Data Quality of a Clinical Trial Directly Embedded within the Electronic Medical Record: the Department of Veterans Affairs’ Point-of-Care Clinical Trial Experience
Session Details
Patsamon Rerksirikul
2015 (Arlington) Annual Meeting
Contributed Session
Association between Years of Clinical Trial Experience and Quality of Study data: Findings from HIV Research Centers in Thailand
Session Details
Stacey Slone
2015 (Arlington) Annual Meeting
Contributed Session
Automated Reminders Promote Completion of Long-Term Radon Tests in a Lung Cancer Study
Session Details
Renee Stewart
2015 (Arlington) Annual Meeting
Contributed Session
BARRIERS AND CHALLENGES TO PARTICIPANT RECRUITMENT IN A RANDOMIZED CONTROLLED TRIAL ON ADVANCED CANCER PATIENTS
Session Details
Deokumar Srivastava
2015 (Arlington) Annual Meeting
Contributed Session
Beyond the Assumption of Constant Hazard Rate in Estimating Incidence Rate on Current Status Data with Applications to Phase IV Cancer Trial
Session Details
Soe Soe Thwin
2015 (Arlington) Annual Meeting
Contributed Session
Biostatistical Considerations for VA Cooperative Study #590, “Double-Blind Placebo-Controlled Study of Lithium for Preventing Repeated Suicidal Self-Directed Violence in Patients with Depression or Bipolar Disorder”
Session Details
Kerry Avery
2015 (Arlington) Annual Meeting
Contributed Session
BLINDING IN SURGICAL TRIALS IS POSSIBLE: EXPERIENCES FROM THE ROMIO FEASIBILITY STUDY
Session Details
Catherine Dillon
2015 (Arlington) Annual Meeting
Contributed Session
Building a Strong Data Management Center for the National Institutes of Health’s Stroke Trials Network
Session Details
Steven Julious
2015 (Arlington) Annual Meeting
Contributed Session
Case Studies and Exemplars of Efficient Study Designs in Clinical Trials
Session Details
Paul Thompson
2015 (Arlington) Annual Meeting
Contributed Session
Causal analyses of randomized clinical trials improves understanding
Session Details
Todd MacKenzie
2015 (Arlington) Annual Meeting
Contributed Session
CAUSAL HAZARD RATIO ESTIMATION USING PRINCIPAL STRATIFICATION
Session Details
Trisha Boekhoudt
2015 (Arlington) Annual Meeting
Contributed Session
CHALLENGES IN DATA MANAGEMENT FOR CONSORTIA
Session Details
Lijuan Zeng
2015 (Arlington) Annual Meeting
Contributed Session
CHARACTERIZING REPORTING OF PHASE 3 CROSSOVER TRIALS REGISTERED ON CLINICALTRIALS.GOV
Session Details
Elizabeth Gargon
2015 (Arlington) Annual Meeting
Contributed Session
CHOOSING IMPORTANT HEALTH OUTCOMES FOR COMPARATIVE EFFECTIVENESS RESEARCH: A SYSTEMATIC REVIEW
Session Details
Abhinav Sharma
2015 (Arlington) Annual Meeting
Contributed Session
Clinical outcomes and biomarker expression patterns in diabetics with heart failure: novel insights from the COACH study
Session Details
Emily Dressler
2015 (Arlington) Annual Meeting
Contributed Session
Clinical trial interim strategies for rare even outcomes using Poisson distributions: Extension of Bayesian predictive probability designs
Session Details
Abigail Shoben
2015 (Arlington) Annual Meeting
Contributed Session
Consent bias in cluster randomized trials: Should we be concerned?
Session Details
Carol Van Huysen
2015 (Arlington) Annual Meeting
Contributed Session
Consideration and Early Barrier Assessment for use of Electronic Health Record Access for Remote Source Document Verification in a Clinical Trials Network
Session Details
Lauren Yesko
2015 (Arlington) Annual Meeting
Contributed Session
Creating a Comprehensive Clinical Trial Management System
Session Details
Shannon McDonough
2015 (Arlington) Annual Meeting
Contributed Session
CURRENT STATUS AND LESSONS LEARNED FROM THE IMPLEMENTATION OF THE SWOG LUNG MASTER PROTOCOL
Session Details
Elizabeth Wright
2015 (Arlington) Annual Meeting
Contributed Session
DATA AND SAMPLE REPOSITORIES – HOW ARE ARCHIVED DATA SETS BEING USED?
Session Details
Katelyn Garcia
2015 (Arlington) Annual Meeting
Contributed Session
DATA COLLECTION AND CLEANING FOR PARTICIPANT ENTERED MEDICATIONS: THE STUDY OF NOVEL APPROACHES TO PREVENTION CLINICAL TRIAL
Session Details
William Meurer
2015 (Arlington) Annual Meeting
Contributed Session
Department of Emergency Medicine; Department of Neurology, University of Michigan, Ann Arbor Overview
Session Details
Tracee Williams
2015 (Arlington) Annual Meeting
Contributed Session
DESIGN AND IMPLEMENTATION OF A DYNAMIC AND ELECTRONIC DELEGATION OF STUDY RESPONSIBILITIES AND SIGNATURE LOG
Session Details
Bryan Comstock
2015 (Arlington) Annual Meeting
Contributed Session
DESIGNING A RANDOMIZED CONTROLLED TRIAL WITH CONTINUOUS PATIENT REPORTED OUTCOMES USING A MINIMALLY CLINICALLY IMPORTANT RESPONSE DERIVED EFFECT SIZE
Session Details
Nicole Cockayne
2015 (Arlington) Annual Meeting
Contributed Session
DESIGNING AND IMPLEMENTING A RANDOMISED CONTROLLED TRIAL EVALUATING AN ADJUNCTIVE INTERNET-DELIVERED COGNITIVE BEHAVIOURAL THERAPY PROGRAM ON OUTCOMES OF STANDARD TREATMENT FOR DEPRESSION: UNIQUE CHALLENGES AND LESSONS LEARNED
Session Details
Amy Whitehead
2015 (Arlington) Annual Meeting
Contributed Session
Designing Randomised Controlled Trials based on Pilot Trials: Statistical Issues and Challenges
Session Details
Janice Pogue
2015 (Arlington) Annual Meeting
Contributed Session
Detecting unreported hospitalizations in a multi-national RCT: Looking for a needle in a haystack?
Session Details
David Gillespie
2015 (Arlington) Annual Meeting
Contributed Session
DETERMINING MAXIMAL INTERVENTION BENEFIT IN PUBLIC HEALTH TRIALS USING RANDOMISATION-BASED EFFICACY ESTIMATORS
Session Details
Lauren Yesko
2015 (Arlington) Annual Meeting
Contributed Session
Developing a Site Training and Troubleshooting Plan in the Digital Age
Session Details
Roberta Scherer
2015 (Arlington) Annual Meeting
Contributed Session
Developing the protocol for the standard-of-care treatment arm of the Tinnitus Retraining Therapy Trial
Session Details
Kerry Avery
2015 (Arlington) Annual Meeting
Contributed Session
DEVELOPMENT OF A CORE OUTCOME SET FOR TRIALS IN OESOPHAGEAL CANCER SURGERY
Session Details
Larisa Tereshchenko
2015 (Arlington) Annual Meeting
Contributed Session
Development of an arrhythmia patient council to improve patient engagement and patient centeredness in clinical cardiac electrophysiology research
Session Details
Mae Gordon
2015 (Arlington) Annual Meeting
Contributed Session
Diagnostic Misclassification: Possible Explanation for Unsuccessful Therapeutic Trials of 'Pink Eye’
Session Details
Mayumi Fukuda-Doi
2015 (Arlington) Annual Meeting
Contributed Session
DIFFERENCES IN REGULATORY SYSTEMS GOVERNING CLINICAL TRIALS- COMPARISON BETWEEN JAPAN AND US
Session Details
Munyaradzi Dimairo
2015 (Arlington) Annual Meeting
Contributed Session
Differential reporting of group sequential randomised controlled trials (GS RCT): shortcomings of the CONSORT 2010 statement
Session Details
Ravi Ramjeesingh
2015 (Arlington) Annual Meeting
Contributed Session
Disease Risk Scores: Use in a Retrospective Analysis Regarding Correlation between Time to Adjuvant Chemotherapy Treatment (TTAC) and Disease Outcomes in Early Breast Cancer.
Session Details
William Aitchison
2015 (Arlington) Annual Meeting
Contributed Session
EDC database driven rule based logic - benefits and potential
Session Details
Chengwu Yang
2015 (Arlington) Annual Meeting
Contributed Session
Effects of preterm delivery and early intervention on infants’ mental development: A randomized controlled two-year follow-up study
Session Details
Adelaide Doussau
2015 (Arlington) Annual Meeting
Contributed Session
Ethical tension in cancer randomized controlled trials using placebo: a review of recently published trials.
Session Details
Manoj Humagain
2015 (Arlington) Annual Meeting
Contributed Session
EVALUATION OF ASSOCIATION BETWEEN THE PREVALENCE AND SEVERITY OF PERIODONTAL DISEASES AND ABO BLOOD GROUPS AMONG NEPALESE ADULTS
Session Details
Zhaoyang Teng
2015 (Arlington) Annual Meeting
Contributed Session
Evaluation of Imposing an Additional Requirement and Sample Size Planning for Multi-Regional Clinical Trials.
Session Details
Katie Gillies
2015 (Arlington) Annual Meeting
Contributed Session
EvaLuation of Interventions for informed Consent for randomIsed controlled Trials (ELICIT): developing a core outcome set.
Session Details
Julia Brown
2015 (Arlington) Annual Meeting
Contributed Session
Experience and Benefits arising from The United Kingdom Registered Clinical Trials Unit Network : J Brown on behalf of the UKCRC Registered Clinical Trials Unit Executive
Session Details
Allan Hackshaw
2015 (Arlington) Annual Meeting
Contributed Session
Experience from a national randomized phase III trial to prospectively evaluate a predictive biomarker for chemotherapy, in patients with advanced non-small cell lung cancer
Session Details
Letitia Perdue
2015 (Arlington) Annual Meeting
Contributed Session
Form Design for Participant Data Entry: The Study of Novel Approaches to Prevention Clinical Trial
Session Details
Wen Wan
2015 (Arlington) Annual Meeting
Contributed Session
Graphic Illustration of Interaction Analysis of Three Combination Drugs via a Modified Genetic Algorithm
Session Details
Koko Asakura
2015 (Arlington) Annual Meeting
Contributed Session
Group-sequential strategies for clinical trials with co-primary endpoints
Session Details
Katharine Cooper-Arnold
2015 (Arlington) Annual Meeting
Contributed Session
HOW CAN CLINICAL TRIAL METRICS IMROVE PERFORMANCE AND FUNDER/GRANTEE COMMUNICATION: THE NIH PERSPECTIVE
Session Details
Kerry Avery
2015 (Arlington) Annual Meeting
Contributed Session
HOW CAN PILOT WORK OPTIMALLY INFORM SURGICAL RCTS? A REVIEW OF CURRENT EVIDENCE
Session Details
Katie Neville
2015 (Arlington) Annual Meeting
Contributed Session
HOW CAN WE DELIVER OPTIMUM BENEFITS FOR PATIENTS? MAXIMISING EFFICIENCY WITH A SEAMLESS PHASE II/III TRIAL DESIGN
Session Details
Alison McDonald
2015 (Arlington) Annual Meeting
Contributed Session
How can we improve the efficiency of trial conduct? Views of UK Clinical Trials Units staff
Session Details
Amy Mhatre-Owens
2015 (Arlington) Annual Meeting
Contributed Session
How To Prepare An Informative And Thorough DSMB Report
Session Details
Ian Saldanha
2015 (Arlington) Annual Meeting
Contributed Session
Impact of author conflicts of interest on full publication of RCTs presented at conferences
Session Details
Qiyuan Shi
2015 (Arlington) Annual Meeting
Contributed Session
IMPACT OF PUBLICATION BIAS ON NETWORK META-ANALYSIS: A NETWORK META-ANALYSIS OF PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION DRUGS USING AVAILABLE PUBLIC DATA FROM FDA CLINICAL REVIEWS
Session Details
Matthew Wright
2015 (Arlington) Annual Meeting
Contributed Session
IMPLEMENTATION OF A MEDICATION AND SUPPLY INVENTORY AND RESUPPLY PROCESS - INCREASING THE EFFICIENCY OF THE TRACKING AND DISTRIBUTION OF SUPPLIES IN CLINICAL TRIALS
Session Details
John Podoba
2015 (Arlington) Annual Meeting
Contributed Session
Implementation of a Web-based Minimization Algorithm for Patient Allocation in Clinical Trials
Session Details
Jaemyung Kim
2015 (Arlington) Annual Meeting
Contributed Session
Implementation of Advanced Randomization Algorithm with Integrated Study Drug Tracking
Session Details
Kenneth Schechtman
2015 (Arlington) Annual Meeting
Contributed Session
IMPROVED HEALTH THROUGH EFFICIENT WOOD BURNING COOKSTOVES IN RURAL INDIA: DESIGN OF A CLUSTER RANDOMIZED TRIAL
Session Details
Joerg Hasford
2015 (Arlington) Annual Meeting
Contributed Session
In multinational trials adverse reactions should be analysed by country or region too.
Session Details
Eric Foster
2015 (Arlington) Annual Meeting
Contributed Session
INCLUDING UNCERTAINTY IN THE TARGET PROBABILITY OF DOSE LIMITING TOXICITY IN PHASE I/II STUDIES WITH A DOSE FINDING COMPONENT
Session Details
Maiken Pontoppidan
2015 (Arlington) Annual Meeting
Contributed Session
INCREDIBLE YEARS PARENTS AND BABIES – A RANDOMIZED CONTROLLED TRIAL OF A PARENTING INTERVENTION IN DENMARK
Session Details
Kaleab Abebe
2015 (Arlington) Annual Meeting
Contributed Session
Informative Censoring in the HALT-PKD Study B Trial
Session Details
Zackary Lemka
2015 (Arlington) Annual Meeting
Contributed Session
Integrated Electronic Data Monitoring System for Multi-center Clinical Trials
Session Details
Erik Doffagne
2015 (Arlington) Annual Meeting
Contributed Session
Integrating Central Statistical Monitoring (CSM) in a Quality by Design (QbD) approach for Clinical Trials
Session Details
Sarah Brown
2015 (Arlington) Annual Meeting
Contributed Session
INTERIM SAMPLE SIZE RE-ESTIMATION: SAFEGUARDING THE POWER OF A TRIAL
Session Details
Valeriya Lockwood
2015 (Arlington) Annual Meeting
Contributed Session
INTERNATIONAL CLINICAL TRIALS: IMPLEMENTATION, COORDINATION, AND OBSTACLES
Session Details
Suzanne Hartley
2015 (Arlington) Annual Meeting
Contributed Session
Is dedication all you need to deliver to time and target in a multicentre study? Lessons learned from the UK Prevention of Delirium (POD) study
Session Details
Isabelle Smith
2015 (Arlington) Annual Meeting
Contributed Session
Is pain a predictor of Category 2 pressure ulcers? Comparison of methods used to analyse data from the PURPOSE Pain Cohort Study
Session Details
Jonathan Gibb
2015 (Arlington) Annual Meeting
Contributed Session
Laboratory Information Management Systems for academic trials with complex/multiple cohorts
Session Details
Niravath Polly
2015 (Arlington) Annual Meeting
Contributed Session
LESSONS LEARNED FROM ULTRA-SENSITIVE ESTRADIOL QUANTITATION
Session Details
Polly Niravath
2015 (Arlington) Annual Meeting
Contributed Session
LESSONS LEARNED FROM ULTRA-SENSITIVE ESTRADIOL QUANTITATION
Session Details
SETH OKEYO
2015 (Arlington) Annual Meeting
Contributed Session
MANAGING CLINICAL DATA QUERIES USING AN IN-HOUSE BUILT QUERY MANAGEMENT SYSTEM- QMSPlus
Session Details
Francesca Fiorentino
2015 (Arlington) Annual Meeting
Contributed Session
Managing multiple outcomes in early phase trials
Session Details
Lauren Yesko
2015 (Arlington) Annual Meeting
Contributed Session
Measuring Treatment Adherence and Exposure, and Study Completion
Session Details
Donald Taves
2015 (Arlington) Annual Meeting
Contributed Session
MINIMIZATION CAN PREVENT SELECTION BIAS
Session Details
Graeme MacLennan
2015 (Arlington) Annual Meeting
Contributed Session
Missing data in multi-item patient reported outcome measures: a case study using the the Oxford Knee Score
Session Details
Paola Berchialla
2015 (Arlington) Annual Meeting
Contributed Session
Modeling QoL in osteoarthritis as an RCT outcome using skewed truncated distributions
Session Details
James Moon
2015 (Arlington) Annual Meeting
Contributed Session
MONITORING ACCRUAL ON THE SWOG LUNG MASTER PROTOCOL
Session Details
Talat Almukhtar
2015 (Arlington) Annual Meeting
Contributed Session
MONITORING OF ADVERSE EVENTS REPORTING IN MULTICENTER CLINICAL TRIALS USING A MIXED EFFECT REGRESSION MODEL
Session Details
Monica Shah
2015 (Arlington) Annual Meeting
Contributed Session
NHLBI Heart Failure Network: Turning the Curve on Enrollment in Heart Failure Trials
Session Details
Chengwu Yang
2015 (Arlington) Annual Meeting
Contributed Session
On the relationship between the Modified Rankin Scale (mRS) and the NIH Stroke Scale (NIHSS)
Session Details
Jincheng Shen
2015 (Arlington) Annual Meeting
Contributed Session
Optimal Treatment Regime Estimation in Prostate Cancer Recurrence Management Using Random Forests
Session Details
Kerry Avery
2015 (Arlington) Annual Meeting
Contributed Session
OPTIMISING THE DESIGN OF INTERNAL PILOT WORK TO INFORM EFFICIENT RANDOMISED CONTROLLED TRIALS: ISSUES TO CONSIDER WHEN DEVELOPING PROGRESSION CRITERIA
Session Details
Kabir Soeny
2015 (Arlington) Annual Meeting
Contributed Session
Optimizing Dose Regimens and Fixed Dose Combination Ratios for a Target Concentration
Session Details
Lynda Constable
2015 (Arlington) Annual Meeting
Contributed Session
Overcoming a Trial ‘Adverse Event’: impact and experiences of a temporary suspension of a clinical trial
Session Details
Qian Shi
2015 (Arlington) Annual Meeting
Contributed Session
Performances of modified trial-level surrogacy estimates in binary-survival endpoint scenario
Session Details
Francesca Fiorentino
2015 (Arlington) Annual Meeting
Contributed Session
Pharmacological Interventions for the Prevention of Contrast Induced Nephropathy in High-Risk Adult Patients Undergoing Coronary Angiography: A Systematic Review and Meta-Analysis of Randomised Controlled Trials.
Session Details
Karisse Torres
2015 (Arlington) Annual Meeting
Contributed Session
Presentation of the currentness of data in DMC reports – Learnings from a Randomized Control Trial with Infrequent Study Visit
Session Details
Jiang Yuan
2015 (Arlington) Annual Meeting
Contributed Session
Program-Wide DMCs Pros and Cons - the ISC point of view
Session Details
Joana Sederias
2015 (Arlington) Annual Meeting
Contributed Session
REDUCING ADVERSE EVENTS REPORTING FOR COMMERCIALLY AVAILABLE AGENTS (SUNITINIB AND TEMSIROLIMUS) CAN IMPROVE PHASE II TRIAL EXECUTION
Session Details
Nikki van Leeuwen
2015 (Arlington) Annual Meeting
Contributed Session
REGRESSION DISCONTINUITY DESIGN: SIMULATION AND APPLICATION IN THREE RANDOMIZED TRIALS WITH DICHOTOMOUS OUTCOMES
Session Details
Kseniia Ratushna
2015 (Arlington) Annual Meeting
Contributed Session
RESEARCH OF THE TRAINING LEVEL OF CLINICAL TRIAL SPECIALISTS USING THE SELF-ASSESSMENTS SYSTEMS
Session Details
Catherine Gregor
2015 (Arlington) Annual Meeting
Contributed Session
RESEARCHMATCH: AN ON-LINE REGISTRY TO CONNECT VOLUNTEERS AND CLINICAL RESEARCHERS
Session Details
Christina Yap
2015 (Arlington) Annual Meeting
Contributed Session
Response-Adaptive Randomization in Multi-Arm Selection Trials: Comparison of a Frequentist and Bayesian Approach
Session Details
Pradeep Singh
2015 (Arlington) Annual Meeting
Contributed Session
Robust multivariate test procedure for discrete and continuous outcome measures with application to pediatric cancer survivor study
Session Details
Ruitao LIN
2015 (Arlington) Annual Meeting
Contributed Session
Robust Optimal Interval Design with an Application to Dose Finding in Drug-Combination Trials
Session Details
Anne Daykin
2015 (Arlington) Annual Meeting
Contributed Session
ROLES AND DECISION MAKING OF TRIAL OVERSIGHT COMMITTEES AND THE CONTRIBUTION TO TRIAL CONDUCT: A QUALITATIVE STUDY.
Session Details
Toshimitsu Hamasaki
2015 (Arlington) Annual Meeting
Contributed Session
Sample size considerations for clinical trials with two primary time-to-event outcomes
Session Details
Kristian Brock
2015 (Arlington) Annual Meeting
Contributed Session
Seamless Phase I/II Adaptive Dose-finding Design with Efficacy-Toxicity Trade-offs for Targeted Therapies in Oncology
Session Details
MOISÉS GÓMEZ MATEU
2015 (Arlington) Annual Meeting
Contributed Session
SELECTING THE PRIMARY ENDPOINT IN A RANDOMIZED CLINICAL TRIAL. A CARDIOVASCULAR CASE STUDY
Session Details
Gaurav Sharma
2015 (Arlington) Annual Meeting
Contributed Session
Sensitivity Analysis for the Primary Outcome in a Drug Abuse Trial
Session Details
Lifeng Lin
2015 (Arlington) Annual Meeting
Contributed Session
Sensitivity to excluding treatments in network meta-analysis
Session Details
Karla Hemming
2015 (Arlington) Annual Meeting
Contributed Session
Setting straight the sample size determination for stepped wedge and cluster randomised trials: design effects and illustrative examples
Session Details
Aenne Glass
2015 (Arlington) Annual Meeting
Contributed Session
SMALL-ANIMAL PET/CT STUDY FOR COMPARISON OF PEPTIDE RADIOTRACER CHOLINE AND BOMBESIN FOR PROSTATA CANCER IMAGING IN A PC-3 HUMAN PROSTATE CANCER XENOGRAFT MOUSE MODEL
Session Details
Emily Miller
2015 (Arlington) Annual Meeting
Contributed Session
SOCIAL NETWORK ANALYSIS AND NETWORK MAPPING SHOW THE GROWTH OF COPUBLICATION NETWORKS ON THE ACTION FOR HEALTH IN DIABETES (LOOK AHEAD) CLINICAL TRIAL
Session Details
Zhibao Mi
2015 (Arlington) Annual Meeting
Contributed Session
Statistical Assessment of Rescue Medication Effect in Psychiatric Clinical Trials
Session Details
Mary Redman
2015 (Arlington) Annual Meeting
Contributed Session
Statistical Designs of Master Protocols and on the Design of the SWOG Lung Master Protocol(S1400; Lung-MAP)
Session Details
MARION CAMPBELL
2015 (Arlington) Annual Meeting
Contributed Session
STEPPED WEDGE DESIGNS OR STANDARD CLUSTER TRIAL DESIGNS FOR EVALUATING HEALTHCARE INTERVENTIONS?
Session Details
Lydia Foster
2015 (Arlington) Annual Meeting
Contributed Session
Stopping Early in a Non-Inferiority Trial When the Primary Efficacy Outcome is also the Primary Safety Outcome
Session Details
Nicole Butler
2015 (Arlington) Annual Meeting
Contributed Session
Streamlining Event Adjudication: Moving from a Paper-based to Web-based System
Session Details
Alexandra Stout
2015 (Arlington) Annual Meeting
Contributed Session
STREAMLINING PROTOCOL DESIGN: THE COST OF COMPLEXITY
Session Details
Dorothee Arenz
2015 (Arlington) Annual Meeting
Contributed Session
Strengthening Clinical Research through Institutionalized Clinical Conduct Management
Session Details
Wenle Zhao
2015 (Arlington) Annual Meeting
Contributed Session
Subject Randomization in Studies with Unequal Allocation
Session Details
Petra Schmalz
2015 (Arlington) Annual Meeting
Contributed Session
SUCCESSFUL ESTABLISHMENT OF CLINICAL RESEARCH STRUCTURES AT UNIVERSITY HOSPITAL COLOGNE BY PUBLIC FUNDING
Session Details
Chris Cook
2015 (Arlington) Annual Meeting
Contributed Session
TECHNICAL IMPLEMENTATION OF THE SWOG LUNG MASTER PROTOCOL (S1400; LUNG-MAP)
Session Details
Lee McDaniel
2015 (Arlington) Annual Meeting
Contributed Session
Testing Proportional and Additive Hazards Assumptions
Session Details
Dikla Blumberg
2015 (Arlington) Annual Meeting
Contributed Session
THE DEVELOPMENT OF A REAL-TIME PROTOCOL DEVIATION NOTIFICATION, TRACKING AND RESOLUTION PROCESS IN MULTI-SITE SUBSTANCE USE TREATMENT CLINICAL TRIALS
Session Details
Olympia Papachristofi
2015 (Arlington) Annual Meeting
Contributed Session
THE HUMAN FACTOR IN COMPLEX SURGICAL INTERVENTIONS: ASSESSING THE IMPACT OF SURGEON LEARNING CURVES.
Session Details
Rebecca Lewis
2015 (Arlington) Annual Meeting
Contributed Session
THE IMPACT OF A SURVEY CONDUCTED TO INFORM DEVELOPMENT OF A COMPLEX INTERVENTION TRIAL IN MUSCLE INVASIVE BLADDER CANCER (MIBC)
Session Details
Gillian Gresham
2015 (Arlington) Annual Meeting
Contributed Session
The Impact of Treatment Cycle on Protocol Completion in Randomized Clinical Trials
Session Details
Michelle Snape
2015 (Arlington) Annual Meeting
Contributed Session
THE IMPLEMENTATION AND UTILITY OF SCREENING LOGS IN A RANDOMISED CONTROLLED TRIAL OF PERI-OPERATIVE CHEMOTHERAPY OR SURVEILLANCE IN UPPER TRACT UROTHELIAL CANCER (POUT - CRUK/11/027)
Session Details
Zhiying You
2015 (Arlington) Annual Meeting
Contributed Session
The minimum required number of clusters with unequal cluster sizes in cluster randomized trials
Session Details
Eve Jelstrom
2015 (Arlington) Annual Meeting
Contributed Session
THE NATIONAL DRUG ABUSE TREATMENT CLINICAL TRIALS NETWORK (CTN) INVESTIGATOR TOOLBOX PROJECT: RESOURCES FOR CLINICAL TRIALS MANAGEMENT
Session Details
Eric Foster
2015 (Arlington) Annual Meeting
Contributed Session
THE NETWORK FOR EXCELLENCE IN NEUROSCIENCE CLINICAL TRIALS (NeuroNEXT) PROTOCOL WORKING GROUP DESIGN PHASE EXPERIENCES
Session Details
Amy Ruppert
2015 (Arlington) Annual Meeting
Contributed Session
The Relationship among Toxicity, Response, and Survival Profiles Ultimately Influence Calling a Beneficial Experimental Drug Favorable under Standard Phase I, II, and III Clinical Trial Designs
Session Details
Kevin Wilson
2015 (Arlington) Annual Meeting
Contributed Session
THE USE OF OPEN-SOURCE WEB-BASED TOOLS TO FACILITATE AND SUPPORT AN MRI IMAGING STUDY OF ANTERIOR VAGINAL WALL DESCENT IN WOMEN WITH PELVIC ORGAN PROLAPSE.
Session Details
James Martin
2015 (Arlington) Annual Meeting
Contributed Session
The use of simulation to examine the effects of varying cluster size on the power of stepped wedge cluster randomised trials
Session Details
Robbie Wilson
2015 (Arlington) Annual Meeting
Contributed Session
Timing is everything: Experience from Integrating Drug Supply Management (DSM) systems into eCRF systems.
Session Details
Aenne Glass
2015 (Arlington) Annual Meeting
Contributed Session
To improve the prediction of procedural success after aortic valve implantation: A pilot study (N=60) to identify unconventional, approach-related predictors
Session Details
Agnieshka Baumritter
2015 (Arlington) Annual Meeting
Contributed Session
TRAINING AND CERTIFICATION OF NON-PHYSICIANS FOR DETECTING REFERRAL-WARRANTED RETINOPATHY OF PREMATURITY IN THE TELEMEDICINE APPROACHES TO EVALUATING ACUTE-PHASE RETINOPATHY OF PREMATURITY (E-ROP) STUDY
Session Details
Athanasia Gravani
2015 (Arlington) Annual Meeting
Contributed Session
Training of staff within Randomized Controlled Trials (RCTs) of health-care interventions: a systematic review of the literature
Session Details
Jeannette Lee
2015 (Arlington) Annual Meeting
Contributed Session
TREATMENT OF MALE PARTNERS TO PREVENT RECURRENT BACTERIAL VAGINOSIS IN WOMEN
Session Details
Shelly Lensing
2015 (Arlington) Annual Meeting
Contributed Session
Two-Stage Phase II Design for Simultaneously Evaluating Efficacy and Toxicity of an Anti-Angiogenic Agent for Treating Kaposi Sarcoma
Session Details
Shelly Lensing
2015 (Arlington) Annual Meeting
Contributed Session
Two-Stage Phase II Design without Suspending Accrual for Interim Analysis
Session Details
Jenny Donovan
2015 (Arlington) Annual Meeting
Contributed Session
Understanding recruitment to randomized clinical trials: clear obstacles and hidden challenges for recruiters
Session Details
Olympia Papachristofi
2015 (Arlington) Annual Meeting
Contributed Session
UNRAVELLING THE COMPLEXITIES IN THE ASSESSMENT OF SURGICAL INTERVENTIONS: DECOMPOSING THE COMPLEX STRUCTURE AND ACCOUNTING FOR MULTIPLE PROVIDERS.
Session Details
Leah Forman
2015 (Arlington) Annual Meeting
Contributed Session
USE OF AN ANDROID PHONE APP FOR AUTOMATED TEXT MESSAGING IN INTERNATIONAL SETTINGS
Session Details
Sohail Mulla
2015 (Arlington) Annual Meeting
Contributed Session
Use of core outcome domains among chronic pain clinical trials
Session Details
Carley Prynn
2015 (Arlington) Annual Meeting
Contributed Session
Use of Internet Technology for Training, Certification, and Monitoring in the Gulf Long-Term Follow-up Study (GuLF STUDY)
Session Details
Sharon Kean
2015 (Arlington) Annual Meeting
Contributed Session
Using routinely collected datasets (primary and secondary care) for multi-centre clinical trials
Session Details
Matthew Curry
2015 (Arlington) Annual Meeting
Contributed Session
Utility of a Participant Survey to Assess the Feasibility of a Follow-up Clinical Exam in the Gulf Long-Term Follow-up STUDY (GuLF STUDY)
Session Details
Elizabeth Sugar
2015 (Arlington) Annual Meeting
Contributed Session
Utilizing Clinical Trials to Assess Cost-Effectiveness: Lessons from the MUST Trial
Session Details
Ira Katz
2015 (Arlington) Annual Meeting
Contributed Session
VA Cooperative Study # 590: Double-Blind Placebo-Controlled Study of Lithium for Preventing Repeated Suicidal Self-Directed Violence in Patients with Depression or Bipolar Disorder
Session Details
Anil Kumar
2015 (Arlington) Annual Meeting
Contributed Session
WEBREPORTER - An Automated Solution for Clinical Trials Web Reporting
Session Details
Jonathan Shtaynberger
2015 (Arlington) Annual Meeting
Contributed Session
What is the most popular dose-finding design for phase I oncology trials?
Session Details
Benjamin Rouse
2015 (Arlington) Annual Meeting
Contributed Session
WOULD NETWORK META-ANALYSIS HAVE CHANGED CLINICAL PRACTICE GUIDELINE RECOMMENDATIONS? A CASE STUDY ON FIRST-LINE MEDICAL THERAPIES FOR PRIMARY OPEN-ANGLE GLAUCOMA
Session Details